Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins.
J Med Chem
; 49(21): 6139-42, 2006 Oct 19.
Article
en En
| MEDLINE
| ID: mdl-17034116
A structure-based approach was employed to design a new class of small-molecule inhibitors of Bcl-2. The most potent compound 5 (TW-37) binds to Bcl-2 with a K(i) value of 290 nM and also to Bcl-xL and Mcl-1 with high affinities. Compound 5 potently inhibits cell growth in PC-3 prostate cancer cells with an IC(50) value of 200 nM and effectively induces apoptosis in a dose-dependent manner.
Buscar en Google
Banco de datos:
MEDLINE
Asunto principal:
Sulfonas
/
Benzamidas
/
Gosipol
/
Apoptosis
/
Proteínas Proto-Oncogénicas c-bcl-2
Límite:
Humans
Idioma:
En
Revista:
J Med Chem
Asunto de la revista:
QUIMICA
Año:
2006
Tipo del documento:
Article
País de afiliación:
Estados Unidos